Otello Stampacchia - Net Worth and Insider Trading
Otello Stampacchia Net Worth
The estimated net worth of Otello Stampacchia is at least $178 Million dollars as of 2024-11-05. Otello Stampacchia is the Director, 10% Owner of Morphic Holding Inc and owns about 2,969,582 shares of Morphic Holding Inc (MORF) stock worth over $169 Million. Otello Stampacchia is the CEO, 10% Owner of Omega Alpha SPAC and owns about 501,000 shares of Omega Alpha SPAC (OMEG) stock worth over $5 Million. Otello Stampacchia is also the Director, 10% Owner of Kronos Bio Inc and owns about 3,818,283 shares of Kronos Bio Inc (KRON) stock worth over $4 Million. Details can be seen in Otello Stampacchia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Otello Stampacchia has not made any transactions after 2021-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Otello Stampacchia
Otello Stampacchia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Otello Stampacchia owns 13 companies in total, including Kronos Bio Inc (KRON) , Morphic Holding Inc (MORF) , and Replimune Group Inc (REPL) among others .
Click here to see the complete history of Otello Stampacchia’s form 4 insider trades.
Insider Ownership Summary of Otello Stampacchia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-14 | director & 10 percent owner |
| MORF | Morphic Holding Inc | 2020-12-23 | director |
| REPL | Replimune Group Inc | 2018-07-19 | director & 10 percent owner |
 | | 2019-09-05 | director & 10 percent owner |
| | 2019-04-12 | 10 percent owner |
| | 2018-07-02 | 10 percent owner |
| | 2018-06-20 | 10 percent owner |
| | 2014-10-30 | 10 percent owner |
| | 2021-10-06 | 10 percent owner |
| | 2021-02-10 | 10 percent owner |
| | 2021-01-11 | director & 10 percent owner & Chief Executive Officer |
| | 2021-03-25 | director |
| | 2023-11-02 | 10 percent owner |
Otello Stampacchia Latest Holdings Summary
Otello Stampacchia currently owns a total of 3 stocks. Among these stocks, Otello Stampacchia owns 2,969,582 shares of Morphic Holding Inc (MORF) as of July 1, 2019, with a value of $169 Million and a weighting of 95.1%. Otello Stampacchia owns 501,000 shares of Omega Alpha SPAC (OMEG) as of January 11, 2021, with a value of $5 Million and a weighting of 2.84%. Otello Stampacchia also owns 3,818,283 shares of Kronos Bio Inc (KRON) as of October 14, 2020, with a value of $4 Million and a weighting of 2.06%.
Latest Holdings of Otello Stampacchia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MORF | Morphic Holding Inc | 2019-07-01 | 2,969,582 | 56.99 | 169,236,478 |
| OMEG | Omega Alpha SPAC | 2021-01-11 | 501,000 | 10.10 | 5,060,100 |
| KRON | Kronos Bio Inc | 2020-10-14 | 3,818,283 | 0.96 | 3,665,552 |
Holding Weightings of Otello Stampacchia
Otello Stampacchia Form 4 Trading Tracker
According to the SEC Form 4 filings, Otello Stampacchia has made a total of 0 transactions in Morphic Holding Inc (MORF) over the past 5 years. The most-recent trade in Morphic Holding Inc is the acquisition of 133,333 shares on July 1, 2019, which cost Otello Stampacchia around $2 Million.
According to the SEC Form 4 filings, Otello Stampacchia has made a total of 1 transactions in Omega Alpha SPAC (OMEG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Omega Alpha SPAC is the acquisition of 501,000 shares on January 11, 2021, which cost Otello Stampacchia around $5 Million.
According to the SEC Form 4 filings, Otello Stampacchia has made a total of 1 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 450,000 shares on October 14, 2020, which cost Otello Stampacchia around $9 Million.
Insider Trading History of Otello Stampacchia
- 1
Otello Stampacchia Trading Performance
GuruFocus tracks the stock performance after each of Otello Stampacchia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Otello Stampacchia is -8.15%. GuruFocus also compares Otello Stampacchia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Otello Stampacchia within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Otello Stampacchia's insider trading performs compared to the benchmark.
Performance of Otello Stampacchia
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.31 | | | | | |
| Relative Return to S&P 500(%) | -6.14 | | | | | |
Otello Stampacchia Ownership Network
Ownership Network List of Otello Stampacchia
Ownership Network Relation of Otello Stampacchia
Otello Stampacchia Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Otello Stampacchia is the director & 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Otello Stampacchia made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Otello Stampacchia Mailing Address
Above is the net worth, insider trading, and ownership report for Otello Stampacchia. You might contact Otello Stampacchia via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
